Funding Opportunities & Notices
NEI Audacious Goals Initiative (AGI)
The Audacious Goals Initiative (AGI) for Regenerative Medicine is an effort by NEI to push the boundaries of vision science and restore vision through regeneration of the retina.
- Get an overview of AGI and its area of focus. Explore the AGI website.
- Learn about AGI funding opportunities.
NIH Regenerative Medicine Innovation Project
The Regenerative Medicine Innovation Project (RMIP) was established by the 21st Century Cures Act to accelerate progress in the field by supporting clinical research on adult stem cells, while promoting scientific rigor and protecting patient safety. This initiative is a trans-NIH effort, in coordination with the Food and Drug Administration (FDA).
- Get an overview of the RMIP program and its area of focus. Explore the RMIP website.
- Learn about RMIP funding opportunities
NIH Common Fund
Congress created the NIH Common Fund in 2006 for research programs that cut across multiple divisions at NIH — and that no one division could tackle on its own. Common Fund programs focus on urgent NIH priorities, emerging scientific opportunities, and pressing challenges in biomedical research.
- Get an overview of the Common Fund and its areas of focus. Explore the Common Fund’s website.
- Learn about this year’s Common Fund opportunities. See an overview of Common Fund programs.
- The Common Fund’s High-Risk, High-Reward program helps exceptional scientists pursue creative approaches to major research challenges. Learn about the High-Risk, High-Reward program.
Expertise & Resources
NEI AMD Integrative Biology Initiative
The NYSCF Research Institute and the NEI have generated iPSCs from AMD patients, which are available to the vision research community.
Collaboration opportunities with NCATS
The National Center for Advancing Translational Sciences ' (NCATS) Division of Preclinical Innovation that is dedicated to addressing the scientific and technological challenges in the induced pluripotent stem cell (iPSC) field has a state-of-the-art research facility called the Stem Cell Translation Laboratory (SCTL).
The SCTL is seeking new collaborations to help achieve common goals in iPSC biology in a faster and more coordinated fashion. Prospective collaborators are encouraged to connect with NCATS for timely notification when program updates are announced. Learn more about the proposal process.